Alector, Inc.

General ticker "ALEC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $355.1M (TTM average)

Alector, Inc. does not follow the US Stock Market performance with the rate: -5.6%.

Estimated limits based on current volatility of 6.2%: low 1.03$, high 1.17$

Factors to consider:

  • Earnings expected soon, date: 2025-05-14 bmo
  • Current price 26.0% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [1.38$, 3.87$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.74$, 4.37$]

Financial Metrics affecting the ALEC estimates:

  • Negative: Non-GAAP EPS, $ of -1.23 <= 0.04
  • Negative: Operating cash flow per share per price, % of -52.72 <= 1.79
  • Positive: 22.52 < Shareholder equity ratio, % of 27.08 <= 43.26
  • Negative: negative Net income
  • Negative: negative Operating income
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Inventory ratio change, % of 27.04 > 1.05

Similar symbols

Short-term ALEC quotes

2025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-070.911.11.21.3
Price $

Long-term ALEC plot with estimates

246810Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.4−0.20
ALECS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $133.62MM $97.06MM $100.56MM
Operating Expenses $271.45MM $248.80MM $245.56MM
Operating Income $-137.83MM $-151.74MM $-145.00MM
Non-Operating Income $7.78MM $26.56MM $26.08MM
R&D Expense $210.42MM $192.12MM $185.94MM
Income(Loss) $-130.06MM $-125.18MM $-118.92MM
Taxes $3.25MM $5.21MM $0.13MM
Profit(Loss)* $-133.31MM $-130.39MM $-119.05MM
Stockholders Equity $214.44MM $134.16MM $126.80MM
Assets $787.65MM $621.83MM $468.30MM
Operating Cash Flow $-20.33MM $-184.16MM $-229.91MM
Capital expenditure $4.12MM $2.38MM $1.25MM
Investing Cash Flow $-159.01MM $101.92MM $107.13MM
Financing Cash Flow $4.51MM $2.55MM $81.54MM
Earnings Per Share** $-1.62 $-1.56 $-1.23

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.